This is the case of Mariano Barbacid, who will participate in the round table organized by FEBIOTEC on new approaches in oncology and their clinical implementation. The first day of the event will be opened by Álvaro Rodríguez-Lescure, President of the SEOM (Spanish Society of Medical Oncology) and Head of the Medical Oncology Service at the Hospital General Universitario de Elche, and will also be attended by more representatives from the CNIO, Atrys Health and the Hospital Gregorio Marañón in Madrid.
The opening day will be followed by a series of conferences entitled ‘Treating Oncology’. It will feature presentations by Maria Luisa Toribio, research professor at the Centro de Biología Molecular Severo Ochoa (CBMSO); Manuel Fresno Escudero, professor of microbiology at the Universidad Autónoma de Madrid and head of the CBMSO’s research line; Damián García Olmo, professor of surgery at the Autonomous University of Madrid (UAM), head of the Department of Surgery at the Fundación Jiménez Díaz-Quirón Salud (Madrid); Juan Velasco, director of the Research, Development and Innovation Centre of Lilly España; and Enric Samper, CEO of Nimgenetics.
In the afternoon, it will be the turn for the ASEBIO round tables on immunology and Bioclusters with Bioga, Ander Urruticoechea, scientific director at Onkologikoa and Eva Méndez, head of drug discovery.
On the closing day, the congress begins with a round table on neurology, with the participation of representatives from the CBMSO, the CSIC and Anaxomics. Funding will be the other topic to be addressed with representatives from the CDTI, the State Research Agency and InnorMadrid.
Finally, vaccines will be the focus of the round table with the participation of experts from the CSIC, the CBMSO and the Universidad Autónoma de Madrid.